Eli Lilly & Co. (LLY) Misses Q2 EPS by 46c, Revenue Misses
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,183.46 +0.13%
Revenue Growth %: +26.6%
Financial Fact:
Marketing, selling, and administrative: 1.57B
Today's EPS Names:
OCCI, IPX, ALZN, More
Revenue Growth %: +26.6%
Financial Fact:
Marketing, selling, and administrative: 1.57B
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q2 EPS of $1.25, $0.46 worse than the analyst estimate of $1.71. Revenue for the quarter came in at $6.49 billion versus the consensus estimate of $6.85 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2022 EPS of $7.90-$8.05, versus the consensus of $8.08.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- Paychex (PAYX) Tops Q1 EPS by 2c
- FDA approves Lilly's Olumiant (baricitinib) for pediatric patients 12 years of age and older with severe alopecia areata
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
